FCF Life Sciences Research

FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. We primarily focus on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations. The findings are regularly published in:

VENTURE CAPITAL MONITOR

The FCF Life Sciences Venture Capital Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies, displaying venture capital financing trends in the European Life Sciences industry.

VENTURE CAPITAL REPORT

The FCF Life Sciences Venture Capital Report analyses the latest VC funding activities in the Life Sciences sector. The report provides a detailed investigation on funding dynamics in Europe and the US

  • Sub-sector Analysis
  • Deal Volume Analysis
  • Investor Analysis
  • Cross-Border Analysis
  • Fund Raising Analysis

PUBLIC EQUITY MONITOR

The FCF Life Sciences Public Equity Monitor comprises of listed small- and midcap companies, headquartered in Europe, from the biotechnology, pharma and med-tech sectors. The Monitor is a derivative of the FCF Valuation Monitor, adjusted to valuation and performance metrics suited for the Life Sciences sector.

The analysis focuses on

  • Performance and Valuation Analysis
  • Break-even Analysis
  • Share Price Potential Analysis
  • Shareholder Analysis
  • Liquidity Analysis

IPO REPORT

The FCF Life Sciences IPO Report examines recent IPO trends in the Life Sciences sector, with a strong focus on the comparison of European and US characteristics

  • Size Segment Analysis
  • Sub-sector Analysis
  • Investor Analysis
  • Liquidity Analysis
  • Share Pricing / Trading Analysis
  • Underwriter Analysis

OTHER PUBLICATIONS & NEWS